This consensus guideline discusses the electrocardiographic phenomenon of beat-to-beat QT interval variability (QTV) on surface electrocardiograms. The text covers measurement principles, physiological basis, and clinical value of QTV. Technical considerations include QT interval measurement and the relation between QTV and heart rate variability. Research frontiers of QTV include understanding of QTV physiology, systematic evaluation of the link between QTV and direct measures of neural activity, modelling of the QTV dependence on the variability of other physiological variables, distinction between QTV and general T wave shape variability, and assessing of the QTV utility for guiding therapy. Increased QTV appears to be a risk marker of arrhythmic and cardiovascular death. It remains to be established whether it can guide therapy alone or in combination with other risk factors. QT interval variability has a possible role in non-invasive assessment of tonic sympathetic activity.
For proper distribution of preventative resources, a more robust method of cardiac risk stratification should be encouraged in addition to merely reduced ejection fraction. To this end the QRS-T angle, an electrocardiogram (ECG)-derived measure of the difference in mean vectors of depolarization and repolarization, has been found associated with sudden cardiac death and other mortal and morbid outcomes in multiple observational studies over the past decade. The use of both frontal and spatial QRS-T angle in the prediction of future cardiac events including sudden cardiac death, all-cause mortality, and further cardiac morbidity is reviewed here.
Background
Asymptomatic individuals account for a majority of sudden cardiac deaths (SCDs). Development of effective, low-cost, and non-invasive SCD risk stratification tools are necessary.
Methods and Results
Participants from the Atherosclerosis Risk in Communities study and Cardiovascular Health Study (n=20,177; age 59.3±10.1 years; age range 44–100; 56% female; 77% white) were followed for 14.0 years (median). Five ECG markers of global electrical heterogeneity (GEH) (sum absolute QRST integral, spatial QRST angle, spatial ventricular gradient (SVG) magnitude, SVG elevation, and SVG azimuth) were measured on standard 12-lead ECGs. Cox proportional hazards and competing risks models evaluated associations between GEH ECG parameters and SCD. A SCD competing risks score was derived using demographics, comorbidities, and GEH parameters. SCD incidence was 1.86 per 1,000 person-years. After multivariable adjustment, baseline GEH parameters and large increases in GEH parameters over time were independently associated with SCD. Final SCD risk scores included age, sex, race, diabetes, hypertension, coronary heart disease, and stroke, and GEH parameters as continuous variables. When GEH parameters were added to clinical/demographic factors, the C-statistic increased from 0.777 to 0.790 (p=0.008), the risk score classified 10-year SCD risk as high (>5%) in 7.2% of participants, 10% of SCD victims were appropriately reclassified into a high-risk category, and only 1.4% of SCD victims were inappropriately reclassified from high- to intermediate-risk. Net reclassification index was 18.3%.
Conclusions
Abnormal electrophysiological substrate quantified by GEH parameters is independently associated with SCD in the general population. Addition of GEH parameters to clinical characteristics improves SCD risk prediction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.